Abstract
Tick-borne relapsing fever (TBRF) is endemic to Israel. Since 2004, the Israel Defence Forces (IDF) has mandated the prophylaxis of tick-bitten subjects with a five-day doxycycline course. We examined the safety and effectiveness of this policy in preventing TBRF. We analyzed the records from January 2004 to January 2007, and identified all reported events of tick bites or TBRF cases. Data were available on 27 events in which 816 soldiers have undergone physical examination following exposure, and seven TBRF cases were recorded in this group—an attack rate of 0.86% compared with the expected rate of 5.34% from previous army data (relative risk [RR] = 0.16). Of those screened, 128 (15.7%) had tick-bite and were intended for prophylaxis, of which four TBRF cases occurred—3.13% attack rate compared with an expected rate of 38.4% in these bitten individuals without prophylaxis (RR = 0.08, number needed to treat = 3). In all cases in which screening and prophylaxis were provided within 48 h of tick bite, complete prevention of TBRF was achieved. No cases of Jarisch–Herxheimer reaction (JHR) was recorded. Tick-bite screening and prophylactic treatment with doxycycline in endemic areas is a practical, safe, and highly effective policy for preventing TBRF.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Cutler SJ (2006) Possibilities for relapsing fever reemergence. Emerg Infect Dis 12:369–374
Hasin T, Davidovitch N, Cohen R, Dagan T, Romem A, Orr N, Klement E, Lubezky N, Kayouf R, Sela T, Keller N, Derazne E, Halperin T, Yavzori M, Grotto I, Cohen D (2006) Postexposure treatment with doxycycline for the prevention of tick-borne relapsing fever. N Engl J Med 355:148–155
Heymann DL (2004) Relapsing fever. In: Control of communicable diseases manual, 18th edn. American Public Health Association, Washington, DC
Kostan M (1996) Ornithodoros tholozani. Insects harmful to men, an introduction to medical anthemology. Kibbus Meuchad, pp 80–82
Egoz N, Lerman Y, Koufman Z (1978) The epidemiology of relapsing fever in the Israel Defense Forces, 1966–76. Harefuah 95:367–370
Lerman Y, Koufman Z, Egoz N (1978) The clinical picture of relapsing fever in the Israel Defense Forces, 1966–76. Harefuah 95:365–367
Sidi G, Davidovitch N, Balicer RD, Anis E, Grotto I, Schwartz E (2005) Tickborne relapsing fever in Israel. Emerg Infect Dis 11:1784–1786
Halperin T, Orr N, Cohen R, Hasin T, Davidovitch N, Klement E, Kayouf R, Baneth G, Cohen D, Yavzori M (2006) Detection of relapsing fever in human blood samples from Israel using PCR targeting the glycerophosphodiester phosphodiesterase (GlpQ) gene. Acta Trop 98:189–195
Hartelt K, Pluta S, Oehme R, Kimmig P (2008) Spread of ticks and tick-borne diseases in Germany due to global warming. Parasitol Res 103(Suppl 1):S109–S116
Randolph SE (2008) Dynamics of tick-borne disease systems: minor role of recent climate change. Rev Sci Tech 27:367–381
Spach DH, Liles WC, Campbell GL, Quick RE, Anderson DE Jr, Fritsche TR (1993) Tick-borne diseases in the United States. N Engl J Med 329:936–947
Author information
Authors and Affiliations
Corresponding author
Additional information
R.D. Balicer and D. Mimouni had equal contribution to this work.
Rights and permissions
About this article
Cite this article
Balicer, R.D., Mimouni, D., Bar-Zeev, Y. et al. Post exposure prophylaxis of tick-borne relapsing fever. Eur J Clin Microbiol Infect Dis 29, 253–258 (2010). https://doi.org/10.1007/s10096-009-0846-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-009-0846-x